Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin, pseudogene (ENSG00000270449), is a non-functional segment of DNA that resembles the functional nucleophosmin (NPM1) gene but lacks protein-coding capacity due to disabling mutations or processing[5]. Pseudogenes, including those derived from nucleophosmin, do not encode active proteins and are generally the result of gene duplication or retrotransposition events that are subsequently inactivated by deleterious mutations[1][5]. As such, this pseudogene is not a therapeutic target, receptor, or enzyme, and does not possess known biological functions, interact with drugs, or serve as a biomarker. Pseudogenes can sometimes have regulatory roles, but there is no evidence that ENSG00000270449 encodes a functional RNA or regulatory molecule. This entity is not suitable for targeting or therapeutic intervention and its inclusion in a drug target context is likely incorrect[1][5]. Summary of issues: - "Nucleophosmin, pseudogene" is not a protein or receptor, but a pseudogene[5]. - It is not a recognized therapeutic, diagnostic, or functional molecular target. - No standard abbreviation, aliases, biological roles, or disease associations for this pseudogene are established. If you are seeking information about the functional nucleophosmin protein, refer to "Nucleophosmin (NPM1)" instead[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin pseudogene.